FDA Adverse Event Summary report: N

UNICEL® DXC 800 SYNCHRON ® CHEMISTRY ANALYZER

MDR report key: 1953323 · Received January 7, 2011

Report

Report Number
2050012-2011-00080
Date Received
January 7, 2011
Date of Event
September 17, 2010
Report Date
September 21, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K042291
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER RECOMMENCED THE USE OF THE MODULAR ASSAY AFTER HAVING THE MODULE DISABLED IN (B)(4) 2010. THE CUSTOMER DID NOT NOTIFY HOTLINE OR FIELD SERVICE TO HAVE THE MODULE VERIFIED FOR USE AGAIN. A BCI FIELD SERVICE ENGINEER (FSE) REPLACED THE UNCLEAN REAGENT SYRINGE WHICH HAD CAUSED THE RELEASE OF BUBBLES INTO THE CUP ASSEMBLY. THE PRECISION RUNS AND QC PERFORMED WITHIN ESTABLISHED SPECIFICATIONS THE ROOT CAUSE FOR THIS EVENT IS THE UNCLEAN REAGENT SYRINGE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS WITHIN THE DATE RANGE (B)(4) 2010, FOR ADDITIONAL REPORTABLE EVENTS/OCCURRENCES. THIS REPORTABLE EVENT IS RELATED TO PREVIOUSLY SUBMITTED MDR 2050012-2010-01011.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO A DISCREPANT DUPLICATE GLUCOSE MODULAR (GLUCM) RESULTS FOR THREE PATIENT SAMPLES GENERATED BY UNICEL DXC 800 SYNCHRON CLINICAL SYSTEM. THE CUSTOMER RUNS PATIENT SAMPLES IN DUPLICATE AND NOTICED THE ORIGINAL SAMPLE DID NOT MATCH THE DUPLICATE. THE ORIGINAL SAMPLE WAS REPEATED ON AN ALTERNATE UNIT WHICH CONFIRMED THE ORIGINAL RUN'S RESULT. PATIENTS 2 AND 3 RESULTS ARE PROVIDED. PATIENT ONE'S RESULTS WERE CAPTURED IN MDR 2050012-2010-01011. THE ERRONEOUS RESULT WAS NOT REPORTED OUT OF THE LABORATORY. PATIENT TREATMENT WAS NOT IMPACTED BY THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXC 800 SYNCHRON ® CHEMISTRY ANALYZER CLINICAL CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. DXC 800 N/A

Patients

Seq Age Sex Outcome Treatment
1